Translational Regenerative Medicine: Market Prospects 2014-2024

NEW YORK, Jan. 6, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Translational Regenerative Medicine: Market Prospects 2014-2024 http://www.reportlinker.com/p0595030/Translational-Regenerative-Medicine-Market-Prospects-2014-2024.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Blood_Supply,_Tissue_Banking_and_Transplantation

Report Details

Our new study shows you the commercial potential of regenerative treatments

What does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our study lets you assess regenerative medicine: cell-based therapies that aim to restore function and regenerate diseased tissues. It lets you assess projected sales at world market, market segment, product and regional level to 2024. You will see financial results, interviews, trends, opportunities, and revenue predictions.

In our investigation you also see qualitative analyses, news R&D and business developments. Our 240 page report provides 122 tables, charts, and graphs. Read the full transcripts of three exclusive expert opinion interviews from leading industry specialists informing your understanding and allowing you to assess prospects for investments and sales: - Dr. Alan Trounson - President, California Institute for Regenerative Medicine (CIRM) - Professor Francois Berthiaume - Associate Professor of Biomedical Engineering, Rutgers University, New Jersey - Dr. William Dolphin - CEO, Avita Medical You will find prospects for submarkets and products In addition to analyses of the overall world market, you will see revenue forecasting of three world-level submarkets to 2024: Stem cell therapy Tissue engineered products Gene therapy

Also, you will discover how leading products - including Apligraf, Dermagraft, ReCell, Osteocel Plus, Trinity Evolution and Neovasculgen - perform from 2014 to 2024. You will find business research and analysis with individual revenue forecasts and discussions. What are the prospects in leading regions and countries? There are many commercial opportunities in developed and developing countries. You discover individual revenue forecasts to 2024 for regions, with discussions of countries: US Europe Asia Pacific - including Japan, China, India, South Korea and Australia Rest of the world - including Brazil

This decade, revenues from the Asia-Pacific region will be the fastest-growing worldwide. Revenues in many countries will multiply many times from 2014 to 2024, our analyses show. Research and development - potential in this emerging industry What's happening in the R&D pipeline for translational regenerative medicine? Our study shows developmental trends: Diabetes treatments Cardiovascular and cardiology treatments Cancer therapy Ocular (ophthalmological) uses - treating eye diseases Wound care Treatments for neurological disorders

Discover how science and technology is changing translational regenerative medicine. Our investigation shows you trends and outlooks, exploring matters affecting the sector. What issues affect the regenerative treatments and industry market? Our study lets you assess industry trends and outlooks. You will find discussions, including qualitative analyses: Tissue engineering - including 3D bioprinting and organ transplants Autologous chondrocyte implantation (ACI) Haematopoietic stem cell transplantation and other cellular treatments Orthobiologics, biomaterials, neuroprotection and nanotechnology Gene therapy, including delivery and viral vectors Bone marrow material and human embryonic stem cells Mesenchymal stem cell technologies Skin regeneration, wound repair, cosmetic uses and treating degenerative disorders Treatment of leg ulcers, cartilage, livers, hearts and eyes

Original post:
Translational Regenerative Medicine: Market Prospects 2014-2024